Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 73

Similar articles for PubMed (Select 16018913)

2.

Sample size of randomized double-blind trials 1976-1991.

Mulward S, Gotzsche PC.

Dan Med Bull. 1996 Feb;43(1):96-8.

PMID:
8906985
3.

How to anticipate the assessment of the public health benefit of new medicines?

Massol J, Puech A, Boissel JP; Participants inRound Table No 7, Giens XXII.

Therapie. 2007 Sep-Oct;62(5):427-35. doi: 10.2515/therapie:2007071. Epub 2008 Jan 19.

PMID:
18206104
4.

Composite outcomes in randomized clinical trials: arguments for and against.

Ross S.

Am J Obstet Gynecol. 2007 Feb;196(2):119.e1-6.

PMID:
17306647
5.
6.

The respective roles of controlled clinical trials and cohort monitoring studies in the pre- and postmarketing assessment of drugs.

Vray M, Hamelin B, Jaillon P; Round Table No.2, Giens XX.

Therapie. 2005 Jul-Aug;60(4):339-44, 345-9. English, French.

PMID:
16268434
7.

Randomised controlled trials of conventional antipsychotic versus new atypical drugs, and new atypical drugs versus clozapine, in people with schizophrenia responding poorly to, or intolerant of, current drug treatment.

Lewis SW, Davies L, Jones PB, Barnes TR, Murray RM, Kerwin R, Taylor D, Hayhurst KP, Markwick A, Lloyd H, Dunn G.

Health Technol Assess. 2006 May;10(17):iii-iv, ix-xi, 1-165.

8.

Dynamic wait-listed designs for randomized trials: new designs for prevention of youth suicide.

Brown CH, Wyman PA, Guo J, Peña J.

Clin Trials. 2006;3(3):259-71.

PMID:
16895043
9.

[Pharmacological therapy of obesity].

Pagotto U, Vanuzzo D, Vicennati V, Pasquali R.

G Ital Cardiol (Rome). 2008 Apr;9(4 Suppl 1):83S-93S. Italian.

PMID:
18773755
10.

A study design to assess the safety and efficacy of on-pump versus off-pump coronary bypass grafting: the ROOBY trial.

Novitzky D, Shroyer AL, Collins JF, McDonald GO, Lucke J, Hattler B, Kozora E, Bradham DD, Baltz J, Grover FL; VA #517 Randomized On/Off Bypass (ROOBY) Study Group.

Clin Trials. 2007;4(1):81-91.

PMID:
17327248
11.

Composite outcomes in cardiovascular research: a survey of randomized trials.

Lim E, Brown A, Helmy A, Mussa S, Altman DG.

Ann Intern Med. 2008 Nov 4;149(9):612-7.

PMID:
18981486
12.

Composite outcomes in clinical trials: uses and problems.

Carneiro AV.

Rev Port Cardiol. 2003 Oct;22(10):1253-63. English, Portuguese.

13.
14.
15.

Blinded sample size reestimation in non-inferiority trials with binary endpoints.

Friede T, Mitchell C, Müller-Velten G.

Biom J. 2007 Dec;49(6):903-16.

PMID:
17726715
16.

Long-term outcome of cognitive behaviour therapy clinical trials in central Scotland.

Durham RC, Chambers JA, Power KG, Sharp DM, Macdonald RR, Major KA, Dow MG, Gumley AI.

Health Technol Assess. 2005 Nov;9(42):1-174. Review.

17.

Evaluating the benefit of event adjudication of cardiovascular outcomes in large simple RCTs.

Pogue J, Walter SD, Yusuf S.

Clin Trials. 2009 Jun;6(3):239-51. doi: 10.1177/1740774509105223.

PMID:
19528133
18.

Statistical power of negative randomized controlled trials presented at American Society for Clinical Oncology annual meetings.

Bedard PL, Krzyzanowska MK, Pintilie M, Tannock IF.

J Clin Oncol. 2007 Aug 10;25(23):3482-7.

19.

On testing simultaneously non-inferiority in two multiple primary endpoints and superiority in at least one of them.

Röhmel J, Gerlinger C, Benda N, Läuter J.

Biom J. 2006 Dec;48(6):916-33.

PMID:
17240652
20.

Design and endpoints of clinical trials in hepatocellular carcinoma.

Llovet JM, Di Bisceglie AM, Bruix J, Kramer BS, Lencioni R, Zhu AX, Sherman M, Schwartz M, Lotze M, Talwalkar J, Gores GJ; Panel of Experts in HCC-Design Clinical Trials.

J Natl Cancer Inst. 2008 May 21;100(10):698-711. doi: 10.1093/jnci/djn134. Epub 2008 May 13. Review.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk